Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03681769 · ClinicalTrials.gov registry record · Early Phase 1
Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
NCT03681769 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 24 participants.
The verdict
NCT03681769, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
Effective control of chronic pain is a top priority in the United States, as approximately 10% of adults have severe chronic pain - most of which is chronic lower back pain (CLBP). However, despite the advances in neuroscience over the past 20 years, chronic pain is still largely treated with opiate narcotics, much as was done in the Civil War. In addition to the high abuse liability and dependence potential, only 30-40% of chronic pain patients declare they receive satisfactory (\>50%) relief from their pain through pharmacological treatment. In these patients a common clinical practice is to escalate the dose of opiates as tolerance develops - which unfortunately has contributed to escalation in opiate overdose deaths, a resurgence of intravenous heroin use, and $55 billion in societal costs. Consequently there is a critical need for new, treatments that can treat pain and reduce reliance on opiates in individuals with chronic pain. Aim 1. Evaluate repetitive Transcranial Magnetic Stimulation (rTMS) to the dorsolateral prefrontal cortex (DLPFC) as a tool to dampen pain and the engagement of the Pain Network. Hypothesis 1: DLPFC TMS will attenuate the baseline brain response to pain (Pain Network activity) and increase activity in the Executive Control Network (ECN) when the patient is given instructions to 'control' the pain. Aim 2. Evaluate Medial Prefrontal Cortex (MPFC) rTMS as a tool to dampen pain and the engagement of the Pain Network. Hypothesis 1: MPFC TMS will also attenuate the baseline brain response to pain (Pain Network activity) but will not effect the ECN or the Salience Network (SN) when the patient is given instructions to 'control' the pain.
Interventions
- DEVICE iTBS to the left dlPFC
- DEVICE Sham iTBS to the left dlPFC
- DEVICE cTBS to the mPFC
- DEVICE Sham cTBS to the mPFC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2021-03-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03681769
The ClinicalTrials.gov registry entry for NCT03681769 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which iTBS to the left dlPFC is the first listed.
NCT03681769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03681769 about?
NCT03681769 is a clinical study titled "Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent". Effective control of chronic pain is a top priority in the United States, as approximately 10% of adults have severe chronic pain - most of which is chronic lower back pain (CLBP). However, despite the advances in neuroscience over the past 20 years, chronic pain is still largely treated with opiate...
What is the current status of trial NCT03681769?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2019-02-22. Estimated completion is 2021-03-19.
What interventions are being tested in trial NCT03681769?
The interventions under investigation include: iTBS to the left dlPFC (DEVICE), Sham iTBS to the left dlPFC (DEVICE), cTBS to the mPFC (DEVICE), Sham cTBS to the mPFC (DEVICE).
Who is sponsoring clinical trial NCT03681769?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.